Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose

Chinese Medical Journal

Volumn 124, Issue 1, 2011, Pages 144-147

  Su, Jian Bin ^a   Wang, Xue Qin ^a   Chen, Jin Feng ^a   Wu, Gang ^a   Jin, Yan ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Acarbose; Continuous glucose monitoring; Glycemic variability; HbA1c; Insulin treatment; Type 2 diabetes

Indexed keywords

ACARBOSE; GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; DRUG RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEAN AMPLITUDE OF GLYCEMIC EXCURSIONS; MEAN OF DAILY DIFFERENCES; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; TREATMENT DURATION;

ACARBOSE; ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED;

EID: 78651260437     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.01.025     Document Type: Article

References (14)

1. Derr R, Garrett E, Stacy GA, Saudek CD. Is HbA(1c) affected by glycemic instability? Diabetes Care 2003; 26: 2728-2733.
2. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 2007; 30 Suppl 1: S4-S41.
3. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000; 321: 405-412.
4. David C. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28: 1231-1239.
5. Zhou J, Jia W, Bao Y, Ma X, Lu W, Li H, et al. Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes. Med Sci Monit 2008; 14: CR552-CR558.
6. McCall AL, Cox DJ, Crean J, Gloster M, Kovatchev BP. A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus. Diabetes Technol Ther 2006; 8: 644-653.
7. Kubiak T, Hermanns N, Schreckling HJ, Kulzer B, Haak T. Assessment of hypoglycaemia awareness using continuous glucose monitoring. Diabet Med 2004; 21: 487-490.
8. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J P, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
9. Zhou J, Jia WP, Yu M, Yu HY, Bao YQ, Ma XJ, et al. The reference values of glycemic parameters for continuous glucose monitoring and its clinical applications. Chin J Intern Med (Chin) 2007; 46: 189-192.
10. Monnier L, Colette C, Owens DR. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2008; 2: 1094-1100.
11. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005; 19: 178-181.
12. Li Y, Li Q, Li CJ, Wang CJ, Zheng YM, Issa M, et al. Comparison of HbA1c in Chinese patients with type 1 or type 2 diabetes randomized to twice daily insulin lispro low mix 25 or twice daily human insulin mix 30/70. Chin Med J 2009; 122: 2540-2546.
13. Kohnert KD, Augstein P, Heinke P, Zander E, Peterson K, Freyse EJ, et al. Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. Diabetes Res Clin Pract 2007; 77: 420-426.
14. Tibaldi J. Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes. South Med J 2009; 102: 60-66.